Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share - Anti-dilutive Securities (Details)

v3.23.1
Net Loss Per Share - Anti-dilutive Securities (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Jan. 31, 2021
Anti-dilutive securities        
Weighted average number of shares issuable (in shares)   139,747    
Exercise price per share (in dollars per share)   $ 0.012   $ 0.012
Pre-funded warrants exercised (in shares) 114,007 25,740 25,740  
Stock options        
Anti-dilutive securities        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 1,428,867 1,137,612    
Warrants on common stock        
Anti-dilutive securities        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 366,990 367,189    
Restricted Stock Units        
Anti-dilutive securities        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 0 937